FibroGen (FGEN) Misses Q1 EPS by 6c

May 8, 2023 4:23 PM EDT

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $36.16 million versus the consensus estimate of $31.67 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities